Ropivacaine Hydrochloride Injection
Product Images NDC 0143-9266

9 FDA label images from Hikma Pharmaceuticals Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Ropivacaine Hydrochloride (NDC 0143-9266). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Ropivacaine Hydrochloride Injection Usp 1)

Chemical Structure (Ropivacaine Hydrochloride Injection Usp 1)
Chemical structure of Ropivacaine Hydrochloride, showing the molecular formula C17H26N2O·HCl·H2O and molecular weight 328.89. The diagram includes the aromatic ring and the linked functional groups characteristic of Ropivacaine Hydrochloride.*
FDA Label Image

Plb562-wes.1 (Ropivacaine Hydrochloride Injection Usp 2)

Plb562-wes.1 (Ropivacaine Hydrochloride Injection Usp 2)
Ropivacaine Hydrochloride Injection USP 0.2% (2 mg/mL) in a 20 mL single dose vial. The label specifies 40 mg per 20 mL and indicates use for infiltration, nerve block, and epidural administration only, not for intravenous use. It is preservative-free, Rx only, stored at 20 to 25°C, and manufactured by Hikma Pharmaceuticals USA Inc.*
FDA Label Image

Plb563-wes.1 (Ropivacaine Hydrochloride Injection Usp 3)

Plb563-wes.1 (Ropivacaine Hydrochloride Injection Usp 3)
Label for Ropivacaine Hydrochloride Injection, USP 0.2% (2 mg/mL) by Hikma Pharmaceuticals USA Inc. The label indicates 40 mg per 20 mL in 10 single-dose vials. It is for infiltration, nerve block, and epidural administration only, preservative free, and not for intravenous use. Includes drug composition, storage instructions, and manufacturer details.*
FDA Label Image

Plb564-wes.1 (Ropivacaine Hydrochloride Injection Usp 4)

Plb564-wes.1 (Ropivacaine Hydrochloride Injection Usp 4)
Ropivacaine Hydrochloride 0.5% HCl Injection, USP label for 150 mg per 30 mL (5 mg/mL) dosage strength. The label indicates use for infiltration, nerve block, and epidural administration only, not for intravenous administration. The product is preservative free and manufactured by Hikma Farmaceutica (Portugal) with labeling by Hikma Pharmaceuticals USA Inc. Storage instructions specify 20° to 25°C.*
FDA Label Image

Plb565-wes.1 (Ropivacaine Hydrochloride Injection Usp 5)

Plb565-wes.1 (Ropivacaine Hydrochloride Injection Usp 5)
Ropivacaine Hydrochloride Injection, USP 0.5% (5 mg/mL) in a 150 mg per 30 mL (10 x 30 mL single dose vials) package. The label specifies use for infiltration, nerve block, and epidural administration only, not for intravenous use. The product is preservative free, manufactured by Hikma Farmacêutica (Portugal), and distributed by Hikma Pharmaceuticals USA Inc.*
FDA Label Image

Pbp626-wes.1 (Ropivacaine Hydrochloride Injection Usp 6)

Pbp626-wes.1 (Ropivacaine Hydrochloride Injection Usp 6)
Ropivacaine Hydrochloride Injection, USP 7.5 mg/mL (0.75%) in a 20 mL vial, labeled as 150 mg per 20 mL. The label indicates use for nerve block and epidural administration only, not for intravenous use. It is preservative-free and produced by Hikma Pharmaceuticals USA Inc.*
FDA Label Image

Plb627-wes.1 (Ropivacaine Hydrochloride Injection Usp 7)

Plb627-wes.1 (Ropivacaine Hydrochloride Injection Usp 7)
Ropivacaine Hydrochloride Injection USP 0.75% (7.5 mg/mL) in a 20 mL single-dose vial. Label indicates 150 mg per 20 mL total dose, for nerve block and epidural administration only, not for intravenous use. Preservative free, manufactured by Hikma Farmaceutica (Portugal) and distributed by Hikma Pharmaceuticals USA Inc.*
FDA Label Image

Plb628-wes.1 (Ropivacaine Hydrochloride Injection Usp 8)

Plb628-wes.1 (Ropivacaine Hydrochloride Injection Usp 8)
Ropivacaine Hydrochloride 1% Injection, USP 200 mg per 20 mL (10 mg/mL) single-dose vial label. It specifies use for epidural administration only and not for intravenous administration. The label includes storage instructions at 20° to 25°C and indicates the product is preservative free, manufactured by Hikma Farmaceutica (Portugal) and distributed by Hikma Pharmaceuticals USA Inc.*
FDA Label Image

Plb629-wes.1 (Ropivacaine Hydrochloride Injection Usp 9)

Plb629-wes.1 (Ropivacaine Hydrochloride Injection Usp 9)
Label for Ropivacaine Hydrochloride Injection USP 1% (10 mg/mL), 200 mg per 20 mL vial, preservative-free, for epidural administration only, not for intravenous use. The package contains 10 single-dose 20 mL vials. Manufactured by Hikma Farmacêutica in Portugal and distributed by Hikma Pharmaceuticals USA Inc., Berkeley Heights, NJ.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.